StayCalm 42

Queensland, Australia

Short Summary

Leopa BioHealth holds the licencing contract for the commercialisation of StayCalm 42, a revolutionary and scientifically proven stress-relieving beverage.

Highlights

  • StayCalm 42 has been proven through clinical studies to reduce stress
  • Leopa BioHealth holds the global licence to commercialise StayCalm 42
  • StayCalm 42 is ready for commercialisation
  • StayCalm 42 has a global potential in health and well-being, and livestock
  • Estimated total sales $1,712,000 within 12 months of product launch
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Angel Investment Network (“AIN”) is not a Stock Exchange nor does it intend to get recognized as a stock exchange under Securities Contracts Regulation Act, 1956. AIN does not facilitate any online or offline buying, selling or dealing of securities, clearing or settlement of trades of securities. AIN is not a network or a platform for the secondary market trading.

Overview

Target
Rs.10,00,00,000
Minimum
Rs.25,00,000
Investment Raised
N/A
Previous Rounds Rs.2,50,00,000
Stage MVP/Finished Product
Investor Role Silent

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 194,988 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Global Pro
34% raised

16.75% Medical Centres

Victoria, Australia

The C2 Notes offer is a loan note that pays a quarterly coupon payment of 7.75% p.a. and a maturity payment of 9% p.a. - total 16.75% p.a. fixed over 1 year. The loan note facilitates C2 Capital’s building of medical centres and aged care facilities....

Rs. 15,00,00,000

Target

Rs. 12,00,000

Min per Investor

Global Pro
0% raised

JD Sanmed

Queensland, Australia

We are offering a single medical device that combines three devices (otoscope, dermatoscope and ophthalmoscope). Unlike similar products of other manufacturers, our device provides modern technology, multi-functionality, compact design

Rs. 3,00,00,000

Target

Rs. 51,000

Min per Investor

0% raised

Swirlit Beverage Co

New South Wales, Australia

Healthy lives start with a smile. So we make healthy drinks, developed by a dentist, backed by science, that taste great and provide instant fresh breath. Swirlit is the flagship product of Oral Health Innovations P/L with a pipeline of new products.

Rs. 2,50,00,000

Target

Rs. 25,00,000

Min per Investor

load one similar proposal